Stanley Bukofzer
2020 - Assertio Holdings
In 2020, Stanley Bukofzer earned a total compensation of $1.1M as Former Senior Vice President and Chief Scientific and Technical Officer at Assertio Holdings, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $137,014 |
|---|---|
| Salary | $255,003 |
| Stock Awards | $342,906 |
| Other | $337,301 |
| Total | $1,072,224 |
Bukofzer received $342.9K in stock awards, accounting for 32% of the total pay in 2020.
Bukofzer also received $137K in non-equity incentive plan, $255K in salary and $337.3K in other compensation.
Rankings
In 2020, Stanley Bukofzer's compensation ranked 8,342nd out of 13,090 executives tracked by ExecPay. In other words, Bukofzer earned more than 36.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,342 out of 13,090 | 36th |
Division Manufacturing | 3,544 out of 5,624 | 37th |
Major group Chemicals And Allied Products | 1,435 out of 2,257 | 36th |
Industry group Drugs | 1,247 out of 1,957 | 36th |
Industry Pharmaceutical Preparations | 923 out of 1,462 | 37th |
Source: SEC filing on April 12, 2021.
Bukofzer's colleagues
We found five more compensation records of executives who worked with Stanley Bukofzer at Assertio Holdings in 2020.
2020
Arthur Higgins
Assertio Holdings
Chief Executive Officer
2020
Todd Smith
Assertio Holdings
Chief Executive Officer
2020
Daniel Peisert
Assertio Holdings
Chief Financial Officer
2020
Danie1 Peisert
Assertio Holdings
Chief Executive Officer
2020
Mark Strobeck
Assertio Holdings
Chief Operating Officer
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019